Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rxi Pharmaceuticals (RXII)

Rxi Pharmaceuticals (RXII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rxi Pharmaceuticals 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 USA

www.rxipharma.com P: 508-767-3861

Description:

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor. RXi Pharmaceuticals Corporation is based in Worcester, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 1,445
Shares Outstanding, K 4,380
Annual Sales, $ 20 K
Annual Net Income, $ -12,450 K
Last Quarter Sales, $ 60 K
Last Quarter Net Income, $ -1,900 K
60-Month Beta 2.07
% of Insider Shareholders 1.01%
% of Institutional Shareholders 9.91%

Growth:

1-Year Return -94.21%
3-Year Return -99.13%
5-Year Return -99.89%
5-Year Revenue Growth -80.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/14/18
Earnings Per Share ttm -3.30
EPS Growth vs. Prev Qtr 26.09%
EPS Growth vs. Prev Year 69.09%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/08/18

RXII Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -412.15%
Return-on-Assets % -179.54%
Profit Margin % -62,250.00%
Debt/Equity 0.00
Price/Sales 96.28
Price/Cash Flow N/A
Price/Book 0.83
Book Value/Share -0.77
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar